Asian Pacific Journal of Cancer Prevention

  • 제16권13호
  • /
  • Pages.5401-5406
  • /
  • 2015
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Brain Metastases from Solid Tumors: an Institutional Study from South India

  • 발행 : 2015.08.03
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Brain metastases are the most common intra-cranial neoplasms. The incidence is on a rise due to advanced imaging techniques. Aims: The objective of the study was to analyse the clinical and demographic profile of patients with brain metastases from primary solid tumors. Materials and Methods: This is a retrospective single institutional study covering 130 consecutive patients with brain metastases from January 2007 to August 2014. Results: Some 64.6% of the patients were females. The majority were in the sixth decade of life. The site of the primary tumor was the lungs in 50.8% of the cases. The overall median time from the diagnosis of the primary malignancy to detection of brain metastases was 21.4 months. Survival was found to be significantly improved in patients with solitary brain lesions when compared to patients with multiple brain metastases, and in patients undergoing surgical excision with or without cranial irradiation when compared to whole brain irradiation alone. The majority of the cases belonged to the recursive partitioning analysis class II group. Whole brain radiation therapy was delivered to 79% of the patients. Conclusions: Most of the patients with brain metastases in the study belonged to recursive partitioning analysis classes II or III, and hence had poor prognosis. Most of the patients in the Indian context either do not satisfy the indications for surgical excision or are incapable of bearing the high cost associated with stereotactic radiosurgery. Treatment should be tailored on an individual basis to all these patients.

키워드

참고문헌

  1. Akhavan A, Binesh F, Heidari S (2014). Survival of brain metastatic patients in Yazd, Iran. Asian Pac J Cancer Prev, 15, 3571-4. https://doi.org/10.7314/APJCP.2014.15.8.3571
  2. Cai Y, Wang JY, Liu H (2013). Clinical observation of whole brain radiotherapy concomitant with targeted therapy for brain metastasis in Non-small cell lung cancer patients with chemotherapy failure. Asian Pac J Cancer Prev, 14 (10), 5699-703. https://doi.org/10.7314/APJCP.2013.14.10.5699
  3. Delattre JY, Krol G, Thaler HT, et al (1988). Distribution of brain metastases. Arch Neurol, 45, 741‑4. https://doi.org/10.1001/archneur.1988.00520310047016
  4. Duan L, Zeng R, Yang KH, et al (2014). Whole brain radiotherapy combined with stereotactic radiotherapy versus stereotactic radiotherapy alone for brain metastasis: a Meta-analysis. Asian Pac J Cancer Prev, 15, 911-5. https://doi.org/10.7314/APJCP.2014.15.2.911
  5. Erten C, Demir L, Somali I, et al (2013). Cisplatin plus Gemcitabine for treatment of breast cancer patients with brain metastasis; a preferential option for triple negative patients? Asian Pac J Cancer Prev, 14, 3711-7. https://doi.org/10.7314/APJCP.2013.14.6.3711
  6. Fabi A, Felici A, Metro G, et al (2011). Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center. J Exp Clin Cancer Res, 30, 10. https://doi.org/10.1186/1756-9966-30-10
  7. Fang H, Lin RY, Sun MX, et al (2014). Efficacy and survivalassociated factors with geftinib combined with cisplatin and gemcitabine for advanced non-small cell lung cancer. Asian Pac J Cancer Prev, 15, 10967-70.
  8. Gaspar L, Scott C, Rotman M, et al (1997). Recursive partitioning analsis (RPA) of prognostic factors in three radiation therapy oncology group (rtog) brain metastases trials. Int J Radiat Oncol Biol Phys, 37, 745-51. https://doi.org/10.1016/S0360-3016(96)00619-0
  9. Jin J, Zhou X, Liang X, et al (2011). A study of patients with brain metastases as the initial manifestation of their systemic cancer in a Chinese population. J Neurooncol, 103, 649-55. https://doi.org/10.1007/s11060-010-0440-1
  10. Johnson JD, Young B (1996). Demographics of brain metastasis. Neurosurg Clin N Am, 7, 337-44.
  11. Lagerwaard FJ, Levendag PC, Nowak PJ, et al (1999). Identification of prognostic factors in patients with brain metastases: A review of 1292 patients. Int J Radiat Oncol Biol Phys, 43, 795-803. https://doi.org/10.1016/S0360-3016(98)00442-8
  12. Liu WJ, Zeng XT, Qin HF, et al (2012). Whole brain radiotherapy plus chemotherapy in the treatment of brain metastases from lung cancer: A meta-analysis of 19 randomized controlled Trials. Asian Pac J Cancer Prev, 13, 3253-8. https://doi.org/10.7314/APJCP.2012.13.7.3253
  13. Miabi Z (2011). Metastatic brain tumors: a retrospective review in East Azarbyjan (Tabriz). Acta Med Iran, 49, 115-7.
  14. Saha A, Ghosh SK, Roy C, et al (2013). Demographic and clinical profile of patients with brain metastases: A retrospective study. Asian J Neurosurg, 8, 157-61. https://doi.org/10.4103/1793-5482.121688
  15. Sawaya R, Ligon BL, Bindal RK (1994). Management of metastatic brain tumors. Ann Surg Oncol, 1, 169-78. https://doi.org/10.1007/BF02303562
  16. Song WG, Wang YF, Wang RL, et al (2013). Therapeutic regimens and prognostic factors of brain metastatic cancers. Asian Pac J Cancer Prev, 14, 923-7. https://doi.org/10.7314/APJCP.2013.14.2.923
  17. Subramanian A, Harris A, Piggott K, et al (2002). Metastasis to and from the central nervous system: The 'relatively protected site'. Lancet Oncol, 3, 498‑507. https://doi.org/10.1016/S1470-2045(02)00819-7
  18. Yanamoto M, Serizawa T, Shuto T, et al (2014). Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol, 15, 387-95. https://doi.org/10.1016/S1470-2045(14)70061-0